Oncology Corporate Profile
Etubics Corporation is a clinical stage biotechnology company focused on developing immunotherapeutics for the treatment of cancer and vaccines against infectious diseases. The Company has a pipeline of product candidates based on our proprietary, advanced generation viral vector platform the Etubics Platform to generate both T cell mediated and antibody responses and its complimentary manufacturing human-based cell line.
Website: http://www.etubics.com
Brand / Product | Class | Area of Study | Phase | Partnership |
---|---|---|---|---|
ETBX-011 | immunotherapy | Colorectal cancer | II | |
ETBX-011 | immunotherapy | Breast cancer | Preclinical | |
ETBX-011 | immunotherapy | Head & Neck cancer | Preclinical |
View additional information on product candidates here »